1887

n Cardiovascular Journal of South Africa - Additional benefits of RAS blockade in the treatment of black hypertensives using valsartan/hydrochlorothiazide combination : drug trends

USD

 

Abstract

A recent trial comparing the non-inferiority of valsartan/hydrochlorothiazide to amlodipine in the treatment of black Americans provides valuable data for the physician wishing to extend the benefits of RAS blockade (reduced progression of kidney disease, diminished new-onset diabetes and congestive heart failure) to their hypertensive black patients.

Loading

Article metrics loading...

/content/cardio/16/5/EJC24038
2005-09-01
2016-12-09
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error